Saturnus Bio, Inc.

Private

San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.saturnusbio.com/

Last Round

Seed

Jun 23, 2026

Total Funding Raised

$50M

Company Overview

Saturnus Bio, Inc. is a biotechnology company that develops precision medicines using targeted gene modulation to treat rare genetic cardiomyopathies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

precision medicinegene therapycardiomyopathydrug discoverybiotech startupgenetic heart diseasebuild-to-buygene modulationcomputational biologytherapeutic platformrare diseasenon-viral deliveryheart failure researchbiotech incubatordrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Saturnus Bio, Inc. Comps

Public and private peers based on sector, stage, and business model.

Saturnus Bio, Inc. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Saturnus Bio, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Jun 23, 2026

View all Funding Rounds

Saturnus Bio, Inc. Investors

Notable investors and investment history

Saturnus Bio, Inc. investors
Investor	Rounds
Versant Ventures	Seed

View all Investors

Saturnus Bio, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Saturnus Bio, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Saturnus Bio, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California

Year Founded2026

Last FundingJun 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.